https://dream.weekday.works/redirectToHiringCopilotExtension/

Applying computer science and data science in biology

Rakesh Barve, Ph.D

Tim Demakis

Maulik Nanavaty

Hutch Fishman

POSITIVE

NEGATIVE

NEUTRAL

PharmStars

nference leverages the top academic minds, world-class researchers, and real-time access to multimodal, patient-level data to accelerate drug development innovation, generate evidence, and improve clinical trial processes. nSights, our flagship software platform, delivers the most comprehensive biological and clinical insights into patient care.

Provider of electronic medical records datasets

More than 2.3 million people worldwide are diagnosed with #BreastCancer each year, making it the most common cancer among women globally. Join nference this week at the San Antonio Breast Cancer Symposium ( #SABCS ), a leading event bringing together experts, researchers, and clinicians, to share groundbreaking advancements in breast cancer research and care. At nference, we harness real-world evidence ( #RWE ) from leading medical institutions, including the Mayo Clinic and Duke Health , to drive transformative oncology research. By unlocking the potential of fully de-identified, longitudinal, #Multimodal data, we are accelerating breakthroughs in biomarker discovery, clinical trial optimization, and personalized medicine. See our #nSights platform in action at SABCS—combining #AI -driven insights from clinical notes, imaging, genomics, and laboratory data to deliver actionable, real-world evidence. Connect with nference leaders for a live demo of nSights: Aaron Mathias , VP, Business Development & Corporate Strategy Christian Anderson , Senior Director, BioPharma Partnerships Sadhna Kohli , PhD, Director, Scientific Solutions Learn more about nference and our federated #nSights platform that is transforming healthcare through real-world data and AI: nference.com Request a live demo of the nSights #AI RWE platform: https://lnkd.in/eqWTyzTd #SABCS2024 #BreastCancerAwareness #RealWorldEvidence #WomeninStem #PrecisionMedicine #nference #AIinHealthcare #OncologyInnovation

nference

Did you know? Over 1.5 million people worldwide are diagnosed with #BloodDisorders such as leukemia, lymphoma, and anemia each year. This underscores the urgent need for cutting-edge research and innovative treatments in hematology. Join nference at the American Society of Hematology (ASH) Annual Meeting this weekend to learn how we are advancing hematology research through real-world evidence and AI-driven insights. The ASH Annual Meeting is the premier event for leading experts, researchers, and clinicians to share breakthroughs in #Hematology research and patient care. Visit Booth #1557 to: • Discover our federated data platform: Learn how we integrate fully de-identified longitudinal, #Multimodal data to tackle complex challenges in hematology, from rare blood disorders to hematologic malignancies. • Leverage real-world evidence: Explore how our platform enhances #ClinicalTrial design, accelerates biomarker discovery, and improves patient care while maintaining the highest standards of data privacy and security. • Experience a live demo: See our #nSights platform in action—combining AI insights from clinical notes, imaging, genomics, and laboratory data to deliver actionable, real-world evidence ( #RWE ). Connect with nference leaders: Aaron Mathias , VP, Business Development & Corporate Strategy AJ Venkatakrishnan, PhD, SVP, A.I. Partnerships Sadhna Kohli , PhD, Director, Scientific Solutions Michiel JM Niesen , PhD, Senior Director of Biomedical Research Bruce Johnson , Biotech and Pharma Executive Allison Smither, PhD , Lead Research Scientist At nference, we are proud to partner with world-class institutions, including Mayo Clinic and Duke Health , to unlock the potential of de-identified healthcare data. Together, we are accelerating precision medicine and improving patient outcomes in difficult to treat and diagnose blood disorders. We look forward to connecting with you at #ASH to explore how our platform can support your research and clinical programs. Learn more about nference and our federated #nSights platform that is transforming healthcare through real-world data and AI: nference.com Request a live demo of the nSights #AI RWE platform: https://lnkd.in/eqWTyzTd #ASH2024 #HematologyInnovation #RealWorldEvidence #PrecisionMedicine #nference #AIinHealthcare

John Halamka, President of Mayo Clinic Platform Mayo Clinic describes four new #AI tools that are making #healthcare more powerful, more accurate and more #equitable . Learn more about how digital #technology , #data and AI can transform #health systems in the World Economic Forum report, Transforming Healthcare: Navigating Digital Health with a Value-Driven Approach: https://ow.ly/kTXX50Ua7nA #HealthEquity

World Economic Forum

Congrats to the Anumana team for the latest recognition, this time from Fast Company ’s ‘The 8 Next Big Technologies in Health for 2024” https://lnkd.in/efaM5j7J #Anumana - For #detecting #diseases #earlier Cardiovascular diseases remain the leading cause of death in the U.S. and across the globe. Anumana is tackling this by enhancing the utility of the electrocardiogram (ECG) with AI algorithms, so that clinicians can detect diseases earlier and more confidently. The ECG-AI algorithms were developed and trained using a real-world deep dataset from leading healthcare institutions and have been evaluated by the FDA.

Venky Soundararajan

Over 50% of #RareDisease cases go undiagnosed! Federated data platforms can unlock critical insights while preserving patient privacy, enabling more accurate disease diagnoses and accelerating the development of effective treatments. nference 's SVP of Strategic AI Partnerships, AJ Venkatakrishnan , Ph.D., will participate in a distinguished panel discussion today hosted by Alexion Pharmaceuticals, Inc. The panel will address the critical role of federated data sharing in advancing research and treatment for rare diseases. Panel Participants: - Amit Gulwadi , VP Head of Transformation - R&D at Alexion Pharmaceuticals, Inc. - Anders Tveteraas , Global Head, Patient Solutions and Services at Novartis - Jen Horonjeff , CEO at Savvy Cooperative By nature, rare diseases impact a limited portion of the population, presenting unique challenges in data collection and analysis due to the small number of cases distributed across diverse geographies. #Federated data enables collaboration across institutions while preserving data and patient privacy, ultimately leading to a more comprehensive understanding of rare diseases and fostering the development of innovative therapies. nference is dedicated to advancing the understanding of complex diseases, including rare conditions. Our federated data platform—created in partnership with leading healthcare institutions including the Mayo Clinic and Duke Health —enables unparalleled access to fully de-identified multimodal data across millions of #longitudinal patient journeys. By combining insights from clinical notes, imaging, genomics, and other critical data modalities, nference empowers researchers to accelerate discovery, optimize #clinicaltrials , and enhance patient care, unlocking new possibilities for rare disease research and treatment. Event details: https://lnkd.in/eA-28mmS Learn more about nference and our federated #nSights platform that is transforming healthcare through real-world data and AI: nference.com Request a live demo of our nSights platform: https://lnkd.in/eqWTyzTd #RareDiseaseResearch #FederatedData #FederatedLearning #nference #RealWorldEvidence #AlexionPharmaceuticals HLTH Inc.

We incorporate data science into all elements of our Helicon discovery platform. Now, we’re excited to announce a new partnership that will greatly expand our ability to deploy these tools throughout clinical drug development. We’re teaming up with nference to utilize nference’s proprietary nSights platform to advance the development of FOG-001, our clinical-stage investigational therapy for the treatment of colorectal cancer and other solid tumors. Through nference’s vast database of real-world patient data, and their custom-built AI and machine learning models, we’ll be able to run more efficient clinical trials and improve the targeting of our programs — with the ultimate goal of improving the precision and success of our pipeline of potentially extraordinary medicines. Read the full press release here: https://bit.ly/3ARcWDI #CreatingExtraordinaryMedicines #Biotech #Oncology

Parabilis Medicines

Today, nference announced a strategic research and data science partnership with Parabilis Medicines focused on accelerating the clinical development of Parabilis’ lead program, FOG-001, in colorectal cancer. This partnership will grant Parabilis access to nference’s extensive repository of de-identified longitudinal, #multimodal clinical data, sourced from leading healthcare institutions, to support their precision medicine efforts. Through the nSights platform, nference’s advanced machine learning models will provide insights to contextualize Parabilis’ clinical trial data, enabling identification of clinical #biomarkers and real-world patient outcomes. The partnership aims to optimize patient cohort selection and enhance the targeting capabilities of FOG-001, a beta-catenin inhibitor now in a Phase 1/2 trial for colorectal cancer. “The nSights platform will enable us to tap into a large depth of real-world, multimodal clinical data, helping us identify optimal patient populations and improve the targeting of our programs. By combining advanced #AI , robust computational methods, and a continuous learning system built on our growing data repository, we are creating a transformative platform that not only accelerates drug discovery and development but also increases the precision and success of our therapeutic programs,” said Dr. Brandon Allgood , Chief Data Science Officer at Parabilis. Read the press release: https://lnkd.in/ekHTGAHW Learn more about nference and our software platform that is transforming healthcare through real-world data and AI: nference.com Request a live demo of our AI software platform: https://lnkd.in/eqWTyzTd #nference #RealWorldData #PrecisionMedicine #ColorectalCancer #Parabilis #ClinicalData #CancerResearch

Today, the Harvard Business School Healthcare Alumni Association hosted a #Leadership in 2025 & Beyond panel with nference 's Chief Scientific Officer, Venky Soundararajan , PhD. This discussion, moderated by Hise Gibson of Harvard Business School, brought together leaders in healthcare, technology, and business to discuss the evolving role of leadership in shaping the future of the industry. Dr. Soundararajan was joined by: • Amy Edmondson , Novartis Professor of Leadership and Management at Harvard Business School • Michael Nally , CEO of Generate:Biomedicines Thank you to Jay Galeota , President and CEO at Kallyope and Peter Stebbins , VP of Program and Business Development at Sapphiros for inviting nference to participate in this esteemed panel. Learn more about nference and our software platform that is transforming healthcare through real-world data and AI: nference.com Request a live demo of our AI software platform: https://lnkd.in/eqWTyzTd We’re grateful for the opportunity to contribute to this important dialogue on the future of healthcare leadership along with: Dr. Priya Agrawal, MD (BMBCh), MPH [ Merck ], Junaid Bajwa [ Flagship Pioneering ], Peter Barrett [ Atlas Venture ], Tess Cameron [ RA Capital Management ], R. Martin Chavez [ Sixth Street ], Douglas Cole [ Flagship Pioneering ], Jorge Conde [ Andreessen Horowitz ], George Q. Daley, MD, PhD [ Harvard Medical School ], Sean Doherty [ T1D Fund ], John Driscoll [ Walgreens Boots Alliance ], Raches Ella [ Bharat Biotech ], Rory Kelleher [ NVIDIA ], Sach Jain [ Carrum Health ], Bruce D Walker [ Ragon Institute of Mass General Brigham, MIT, and Harvard ], Sir Andrew Witty [ UnitedHealth Group ] #RealWorldEvidence #PrecisionMedicine #Leadership #AI

It was an honor to participate in the #TCT forum on Precision Medicine & Patient-Centered Technologies with visionary leaders like Dr. Jessica Mega , MD ( Stanford University ), Dr. Harlan Krumholz , MD ( Yale New Haven Health ), Dr. Lloyd Minor , MD ( Stanford University School of Medicine ), Dr. Aaron Kaplan , MD ( Dartmouth Hitchcock Medical Center and Clinics ) and Dr. Jay Yadav MD . From co-founding medRxiv that gave #Science a real-time voice to fight the COVID-19 pandemic, to serving on the Boards of legendary companies like Danaher Corporation and Boston Scientific , and presiding as #Dean for Stanford University 's world-renowned Medical School, my luminary colleagues drew from their rich & storied experience to share several compelling perspectives on Precision Medicine. Thanks to the Cardiovascular Research Foundation and Dr. Juan Granada, MD for inviting me to share how nference and our affiliate ventures Anumana and Pramana are advancing a broad-spectrum of multimodal #AI innovations across #diagnostics and #interventions , in close partnership with Mayo Clinic , Duke University Health System , Vanderbilt University Medical Center , Emory Healthcare and Banner Health . Together, we will continue transforming global healthcare in secure and scalable ways that serves every patient. #precisionmedicine #AI #AgeofAI #biomedicine #publichealth #cardiology #nference #mayoclinic #duke #vanderbilt #emory #bannerhealth #healthcare

What do you need to know about Precision Medicine and Patient-Centered Technologies? Join us on Sunday, October 27 at TCT MedTech Innovation Forum to explore the case for personalized device design, decode innovation trends in biomarker discovery and molecular diagnostics, and get up to speed on the newest developments in smart health - harnessing wearables and real-time data for personalized care. This all-star session features moderators Harlan Krumholz , MD, Professor Yale University and Director Yale University/Yale New Haven Hospital Center for Outcomes Research and Evaluation (CORE) ; and Lloyd Minor , MD, Dean, Stanford University School of Medicine ; and discussants Jessica Mega , MD, cardiologist Stanford Health Care and Cofounder Verily ; Venky Soundararajan , Founder and CSO nference ; Jay Yadav MD , Founder & CEO MiRus® ; and Aaron Kaplan , MD, Professor, Dartmouth Hitchcock Medical Center and Clinics ; Founder & Chairman, Conformal Medical . This is just ONE of 15 scintillating panels organized into three full learning tracks: Global Market Dynamics, Hot Topics in Medtech Innovation, and FDA University for Startups. View the program guide now to learn more and customize your day! https://lnkd.in/ghvCJEN6 Cardiovascular Research Foundation

Fogarty Innovation

Actively looking for Linux/ cloud/ DevOps Roles

Bhargavi Bhargavi

Student at Nagpur University

Krushna Wani

Vaibhav Mirashe

Core Java | DSA | SQL | Python | Numpy |Pandas | Matplotlib | Data scraping | HTML | CSS

Ninad Kapadnis

INFOTRIXS is Software Development Company that specializes in providing software solutions. With a team of highly skilled professionals, we strive to deliver projects to our clients. INFOTRIXS is a dynamic software solutions providers that specializes in delivering cutting edge services in website development, Devops implementions, Python Programming, AWS Cloud solutions and educational development services. Join us and let's work together in shaping the technology of tomorrow through our extensive range of services and solutions. Don't miss out on #SoftwareDevelopment #Infotrixs #Educationsupport ! Contact Us : contact@infotrixs.com

🌐 Elevate Your Online Presence with INFOTRIXS Web Development Services! 💻✨ At INFOTRIXS, we transform visions into captivating online experiences. 🚀 Explore our top-notch web development services, where innovation meets functionality. 🔧 From responsive design to seamless user experiences, we craft websites that make a lasting impression. Whether you're a startup or an established enterprise, let's build something extraordinary together. Ready to redefine your digital footprint? Let's talk web development! 💬🌐 #infotrixs #infotrixsteam #WebDevelopment #DigitalInnovation #techexcellence #infotrixsservices #websitedevelopment #websiteservices #landingpage #ecommercewebsite #portfoliowebsite #customwebsite

INFOTRIXS

🎉 Happy New Year from INFOTRIXS ! 🎉 As we bid farewell to the old and embrace the new, INFOTRIXS wishes you a year filled with endless opportunities, innovation, and success! 🚀✨ May 2024 bring you joy, prosperity, and the achievement of your goals. 🌟 Thank you for being a part of our journey, and here's to another year of collaboration and growth! 🌐🤝 Cheers to new beginnings! 🥂 #HappyNewYear #INFOTRIXS #2024Success

Software Engineer Intern at Nference | Codeforces—Specialist | Codechef—4*

Vishwajeet Prasad

I'm a Software Engineer, currently working at Nference as an Intern, a company transforming biomedical data into actionable healthcare insights with strong focus on data privacy and security. My work focuses on developing and optimizing the DICOM Image De-Identification pipeline. Prior experience in API development at Infotrixs and selected participant at Amazon ML Summer School. A bit of competitive programming experience too (Top 70 in IICC'22, Specialist on Codeforces and 4* on CodeChef).  Technical Focus:  - Programming languages: Python, C++, SQL - Database systems: SQLite, PostgreSQL - Cloud & Tools: Google Cloud (VM and Object Storage), Git, Linux  Passionate about technology, software and company building at the intersection of these. Always eager to tackle complex technical challenges and contribute to impactful projects.